Holen Sie sich die Stockscreener-App
20.96
3.71%
0.75
Handel nachbörslich:
20.75
-0.21
-1.00%
Schlusskurs vom Vortag:
$20.21
Offen:
$20.21
24-Stunden-Volumen:
620.19K
Relative Volume:
0.43
Marktkapitalisierung:
$1.04B
Einnahmen:
$239.44M
Nettoeinkommen (Verlust:
$-80.45M
KGV:
-12.86
EPS:
-1.6303
Netto-Cashflow:
$-40.05M
1W Leistung:
+14.29%
1M Leistung:
+13.54%
6M Leistung:
-21.88%
1J Leistung:
+31.66%
1-Tages-Spanne:
$20.21
$21.04
1-Wochen-Bereich:
$18.38
$21.04
52-Wochen-Spanne:
$14.69
$30.81
Staar Surgical Co Stock (STAA) Company Profile
Firmenname
Staar Surgical Co
Sektor
Telefon
(626) 303-7902
Adresse
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
20.96 | 1.00B | 239.44M | -80.45M | -40.05M | -1.6303 |
ISRG
Intuitive Surgical Inc
|
452.58 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.32 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.63 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.88 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.93 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-03 | Eingeleitet | Wedbush | Neutral |
| 2026-01-16 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-04-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-02-12 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-02-12 | Herabstufung | Jefferies | Buy → Hold |
| 2025-02-12 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-03-11 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-05 | Herabstufung | Needham | Buy → Hold |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-09-15 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-03 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-12-28 | Bestätigt | BTIG Research | Buy |
| 2022-12-08 | Eingeleitet | Stifel | Hold |
| 2022-11-07 | Hochstufung | Sidoti | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-28 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-07-09 | Eingeleitet | Oppenheimer | Perform |
| 2021-01-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-10-26 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-31 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-08-06 | Bestätigt | The Benchmark Company | Buy |
| 2020-07-06 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-06-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-06-15 | Eingeleitet | Jefferies | Buy |
| 2019-12-04 | Eingeleitet | BTIG Research | Buy |
| 2018-09-24 | Bestätigt | The Benchmark Company | Buy |
| 2018-08-06 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-11-20 | Bestätigt | The Benchmark Company | Buy |
| 2017-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2017-03-03 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-18 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2013-09-10 | Fortgesetzt | The Benchmark Company | Buy |
| 2013-02-28 | Bestätigt | The Benchmark Company | Buy |
| 2012-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | Eingeleitet | Northland Securities | Outperform |
| 2011-10-25 | Bestätigt | The Benchmark Company | Buy |
| 2010-10-12 | Eingeleitet | Morgan Joseph | Buy |
| 2010-05-11 | Eingeleitet | Benchmark | Buy |
Alle ansehen
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
STAA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
The Chart That Says You're Right on STAAR Surgical - AOL.com
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo! Finance Canada
STAA Should I Buy - Intellectia AI
Stifel cuts Staar Surgical stock price target on weak Q4 results - Investing.com
Staar Surgical Co (STAA) Shares Up 3.28% on Apr 2 - gurufocus.com
Staar Surgical Co (SR3.MU) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Forecast Cut: Is STAAR Surgical Company currently under institutional pressurePortfolio Update Summary & Stock Portfolio Risk Management - baoquankhu1.vn
Market Trend Analysis: The Impact of Recent Innovations on the Intraocular Lens (IOL) Material Market - openPR.com
Leading Companies Fortifying Their Presence in the Implantable Collamer Lens Market - openPR.com
World Phakic Intraocular Lenses (IOL)Market Analysis, Forecast, Size, Trends and Insights - IndexBox
Why STAAR Surgical (STAA) stock is trading lower today - MSN
Vanguard realigns reporting; holds 0 shares of STAAR Surgical (STAA) - Stock Titan
Stocks making big moves this week: Shopify, Winnebago, Coinbase, STAAR Surgical, and Viavi Solutions - theglobeandmail.com
Tudor Investment Corp ET AL Purchases New Position in STAAR Surgical Company $STAA - MarketBeat
Defender Capital LLC. Takes $15.43 Million Position in STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical (STAA) Stock Gains on Cencora-EyeSouth Deal NewsNews and Statistics - IndexBox
Aug Analyst Calls: Can STAAR Surgical Company withstand a market correction2026 Growth vs Value & Weekly Breakout Watchlists - baoquankhu1.vn
STAAR Surgical: Despite Promises Of Improvement, Investors Should Stay Cautious (STAA) - Seeking Alpha
Medtech business QuidelOrtho hires STAAR Surgical legal head as CLO - The Global Legal Post
STAAR Surgical Co stock faces acquisition scrutiny as Alcon deal advances amid analyst caution - AD HOC NEWS
Midday Stock Roundup: Mobix Lab Shares Fall 15% - Orange County Business Journal
STAA gains FDA nod to expand EVO ICL age indication to 60 years - MSN
STAAR Surgical (NASDAQ:STAA) Trading 4.5% HigherWhat's Next? - MarketBeat
STAAR Surgical Company $STAA Stake Boosted by Yunqi Capital Ltd - MarketBeat
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
Alcon Buy Rating Reaffirmed, Despite Failed STAAR Merger, As Eyecare Portfolio Leads - Seeking Alpha
STAAR Surgical (STAA) awards 39,809 RSUs to Interim Co-CEO Andrews - Stock Titan
[Form 4] STAAR SURGICAL CO Insider Trading Activity - Stock Titan
STAAR Surgical (NASDAQ:STAA) Director Acquires $5,425,707.84 in Stock - MarketBeat
STAAR Surgical (NASDAQ:STAA) Director Broadwood Partners, L.P. Purchases 316,017 Shares - MarketBeat
Broadwood boosts STAAR Surgical (STAA) stake with 670K-share open-market buys - Stock Titan
Refractive Vision Correction Market is expected to hit US$ 8.53 - openPR.com
Director at STAAR Surgical (STAA) receives 7,524 long-dated options - Stock Titan
STAAR Surgical (STAA) awards director 7,524 stock options vesting in 2026 - Stock Titan
Director at STAAR Surgical (STAA) receives grant of 7,524 stock options - Stock Titan
Canaccord reiterates Hold on STAAR Surgical stock, $22 target - Investing.com Nigeria
STAAR Surgical Company (NASDAQ:STAA) Q4 2025 earnings call transcript - MSN
Staar Surgical taps Amico Group as Middle East distributor - Arab News PK
STAAR Surgical Co. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
STAAR Surgical Co. Experiences Evaluation Revision Amidst Fluctuating Market Conditions - Markets Mojo
GABELLI & Co INVESTMENT ADVISERS INC. Makes New $4.81 Million Investment in STAAR Surgical Company $STAA - MarketBeat
STAAR Surgical net loss hits USD 18.3M in Q4 2025 - Medical Buyer
STAA: Wells Fargo Lowers Price Target by 47.97% on Staar Surgica - GuruFocus
Wells Fargo & Company Cuts STAAR Surgical (NASDAQ:STAA) Price Target to $16.00 - MarketBeat
STAAR Surgical Company (NASDAQ:STAA) Q4 2025 Earnings Call Transcript - Insider Monkey
STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives - simplywall.st
STAAR Surgical Releases Q4 and Full Year 2025 Financial Results - VisionMonday.com
Canaccord reiterates Hold on STAAR Surgical stock, $22 target By Investing.com - Investing.com Canada
Needham maintains Hold on STAAR Surgical stock after Q4 miss - Investing.com Nigeria
Staar Surgical Posts Q4 Loss After Rejecting Alcon Deal - Medical Device and Diagnostic industry
Finanzdaten der Staar Surgical Co-Aktie (STAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Staar Surgical Co-Aktie (STAA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| Michna Magda | Chief Development Officer |
Mar 12 '26 |
Option Exercise |
0.00 |
6,178 |
0 |
20,622 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 11 '26 |
Buy |
17.52 |
54,764 |
959,558 |
15,508,393 |
| Jiang Wei | Director |
Jan 12 '26 |
Option Exercise |
0.00 |
20,967 |
0 |
66,444 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 09 '26 |
Buy |
22.05 |
27,485 |
606,138 |
15,453,629 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 06 '26 |
Buy |
21.62 |
336,946 |
7,284,281 |
15,356,437 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Jan 07 '26 |
Buy |
22.00 |
66,467 |
1,462,301 |
15,422,904 |
0.50%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):